U.S. Economic Woes Expected To Limit Job Opportunities For Scientists In Industry

Slowdowns in corporate R&D are foreseen, which, experts reason, will cut employment potential for researchers in 1993 The 1993 employment outlook for scientists in industry is marginally optimistic, at best, according to various economic indicators and industry experts. With the exception of a few sectors that, as a result of sustained consumer demand, appear relatively recession-proof, such as the pharmaceutical and biotechnology industries, hiring will be tied to the sluggish recovery of th

Written bySusan L-J Dickinson
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

But it is more than fallible macroeconomic forecasts that cloud the picture of industrial R&D in the near future, analysts say. Other factors include: a new, untested Democratic administration; the world's changing political map; and a shifting perception of just how much basic research, independent of market demands, corporations can afford to finance. All of these ingredients contribute to a puzzle that many analysts and industry insiders are finding difficult to put together.

And though the cyclical swings in the economy and resultant ebb and flow in the demand for new employees are to be expected, some industry insiders are predicting that, with this recession, the nature of corporate R&D may have changed forever.

Although the specifics of President Clinton's first budget will not become known until late winter or early spring, Albert H. Teich, the American Association for the Advancement of Science's director of science and policy programs, says ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies